Alzheimers

TORONTO, May 03, 2023 (GLOBE NEWSWIRE) -- On the weekend of May…

<!-- Name:DistributionId Value:8784461 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4570 -->…

<!-- Name:DistributionId Value:8749547 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…

COLUMBUS, Ohio--(BUSINESS WIRE)--As the population ages, more and more of us are looking for ways to stay in our homes safely. Give some love to your aging loved ones with Valentine’s gifts that don’t come with an expiration date. Cini…

The supplemental new drug application (sNDA) for brexpiprazole in the treatment of agitation associated with Alzheimer’s dementia has been accepted and filed by the FDA under Priority review The FDA target date (PDUFA date) for…

POTOMAC, Md., Dec. 20, 2022 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American: IGC) (“IGC” or the “Company”), today announces that a life sciences presentation has been filed with the SEC on Form 8K and is available…

Next generation SupraAntigen® liposomal vaccine platform augments immunization against pathological targets of Alzheimer’s diseaseNew data on anti-phospho-Tau vaccines confirm safety, tolerability and immunogenicity of ACI-35 and…

– Phase III GRADUATE studies did not meet their primary endpoints of slowing clinical decline in people with early Alzheimer’s – – The level of beta-amyloid removal by gantenerumab was lower than expected – – Topline data will be…